Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 33.5B | 32.4B | 31.2B | 31.7B |
Cost of revenue | 11.6B | 11.2B | 10.7B | 10.1B |
Gross profit | 21.9B | 21.1B | 20.5B | 21.5B |
Operating expense | ||||
Research & development | 2.7B | 2.7B | 2.7B | 2.7B |
Selling general and admin | 10.8B | 10.7B | 10.4B | 10.3B |
Other operating expenses | -23M | 464M | -131M | 862M |
Operating income | 6.5B | 5.5B | 5.8B | 5.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 729M | 719M | 636M | 553M |
Other income expense | -182M | 37M | 170M | 163M |
Pretax income | 5.6B | 4.8B | 5.4B | 5.5B |
Tax provision | 936M | 1.1B | 1.6B | 456M |
Net income | 4.7B | 3.7B | 3.8B | 5.1B |
Basic EPS | 7.3 | 5.5 | 5.7 | 7.5 |
Diluted EPS | 7.2 | 5.5 | 5.6 | 7.5 |
Basic average shares | 642.8M | 663.9M | 629.6K | 635.6K |
Diluted average shares | 642.8M | 663.9M | 629.6K | 635.6K |
EBITDA | 9.8B | 8.6B | 9.0B | 8.9B |
Net income from continuing op. | 4.7B | 3.7B | 3.8B | 5.1B |
Minority interests | -29M | -28M | -26M | -22M |
Preferred stock dividends | — | — | — | — |